IPO registrations (S-1, F-1) · Registrants

Euthymics Bioscience, Inc.

SEC CIK

1066833 · filings on EDGAR ↗

Name on the registration

DOV PHARMACEUTICAL INC

Former names

Euthymics Bioscience Inc (2010–2013); DOV PHARMACEUTICAL INC (2002–2009)

Registration

Form S-1, first filed 2002-01-28, last 2007-06-06; 5 initial registrations, 9 amendments

Outcome

Final prospectus filed 2002-04-25; declared effective 2007-06-25

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

35 BRAINTREE HILL OFFICE PARK, SUITE 304, Braintree, MA 02184

EIN

22-3374365

EDGAR entity type

operating

Insiders and CEO pay

Euthymics Bioscience, Inc. on the corporate pages

Offering terms

Proposed price range

$15.00–$17.00 per share (S-1/A filed 2002-04-24)

Final price

$13.00 per share, below the range (424B1 filed 2002-04-25, an initial public offering)

Shares sold

5,000,000

Gross proceeds

$65,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol DOVP

Lead underwriters

CIBC World Markets (1,870,000 shares); Lehman Brothers (1,870,000 shares); Lazard (935,000 shares); Services LLC (50,000 shares)

Syndicate

Fidelity Capital Markets; BofA Securities (50,000); Piper Sandler (50,000); Wachovia (50,000); Adams Harkness (25,000); Emerging Growth Equities, Ltd (25,000); Leerink Partners (25,000); Pacific Crest Securities (25,000); Parker/Hunter Incorporated (25,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Form 5500 plan sponsor: EUTHYMICS BIOSCIENCE EXACT (EIN (EXACT))
• Form D issuer: Euthymics Bioscience, Inc. EXACT (CIK (EXACT))
• SEC filer: DOV PHARMACEUTICAL INC EXACT (CIK (EXACT))

Filings 16

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

• ERGO SCIENCE CORP MA
• MILLENNIUM PHARMACEUTICALS INC MA
• ESSENTIAL THERAPEUTICS INC MA
• ARQULE INC MA
• ASCENT PEDIATRICS INC MA
• EPIX Pharmaceuticals, Inc. MA
• PRAECIS PHARMACEUTICALS INC MA
• PARATEK PHARMACEUTICALS INC MA
• PREDIX PHARMACEUTICALS HOLDINGS INC MA
• CervoMed Inc. MA

More with this interest.

In other datasets, the same topic (Health) in MA:

• Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))

Interests: Pharmaceutical Preparations · Health